Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • painkiller

    Tag: painkiller

    You Searched For "painkiller"
    USFDA panel votes against Nektar painkiller

    USFDA panel votes against Nektar painkiller

    MD bureau15 Jan 2020 9:00 AM IST
    New Delhi: Independent advisers to the U.S. Food and Drug Administration on Tuesday unanimously voted against Nektar Therapeutics' opioid painkiller...
    OxyContin maker Purdue Pharma agrees to provide proprietary research, other data

    OxyContin maker Purdue Pharma agrees to provide proprietary research, other data

    Medical Dialogues Bureau25 Aug 2019 9:00 AM IST
    OKLAHOMA CITY: The maker of the powerful painkiller OxyContin has agreed to provide access to proprietary research and other data to researchers at...
    Bayer sells Animal Health unit to US drug firm Elanco for USD 7.6 billion

    Bayer sells Animal Health unit to US drug firm Elanco for USD 7.6 billion

    Medical Dialogues Bureau21 Aug 2019 9:00 AM IST
    Bayer said in a statement that the sale, aimed at sharpening the company's focus on life sciences, was expected to be concluded in mid-2020 pending...
    Families say OxyContin maker Purdue Pharma must be held accountable for its role in opioid epidemic

    Families say OxyContin maker Purdue Pharma must be held accountable for its role in opioid epidemic

    Medical Dialogues Bureau5 Aug 2019 9:00 AM IST
    The parents and their supporters rallied outside a Boston courthouse Friday as a judge heard arguments in Massachusetts' lawsuit against Purdue...
    NPPA fixes retail price of 14 combo drugs including Aspirin, Paracetamol, Vitamin D3; Details

    NPPA fixes retail price of 14 combo drugs including Aspirin, Paracetamol, Vitamin D3; Details

    Farhat Nasim27 Jun 2019 4:07 PM IST
    New Delhi: Through a recent notification, the government regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the retail...
    Teva Pharma to settle $85 million opioid claims of Oklahoma

    Teva Pharma to settle $85 million opioid claims of Oklahoma

    Medical Dialogues Bureau27 May 2019 9:00 AM IST
    Oklahoma Attorney General Mike Hunter has alleged that JnJ and Teva Pharma, along with OxyContin maker Purdue Pharma LP, carried out deceptive marking...
    Rochester Drug Cooperative fined $20 million in criminal case against drug distributor over opioids

    Rochester Drug Cooperative fined $20 million in criminal case against drug distributor over opioids

    Medical Dialogues Bureau24 April 2019 9:00 AM IST
    The company where the executives worked, Rochester Drug Cooperative (RDC), is one of the country's largest distributors of prescription opioids. It...
    Lower dose of Pfizer, Eli Lilly blockbuster painkiller tanezumab misses target in late stage study

    Lower dose of Pfizer, Eli Lilly blockbuster painkiller tanezumab misses target in late stage study

    Farhat Nasim20 April 2019 10:00 AM IST
    The drug, tanezumab, belongs to a new category of pain medications that target nerve growth factor, a protein involved in the growth of nerve cells,...
    US to wrap criminal trial of Insys Therapeutics

    US to wrap criminal trial of Insys Therapeutics' executives tied to opioid crisis

    Medical Dialogues Bureau6 April 2019 8:59 AM IST
    BOSTON: Prosecutors on Thursday will present their closing arguments in the trial of the wealthy founder of pharmaceutical company Insys Therapeutics...
    New York sues billionaire family behind maker of OxyContin

    New York sues billionaire family behind maker of OxyContin

    Garima30 March 2019 9:00 AM IST
    NEW YORK: New York is suing the billionaire family behind the company that created OxyContin, joining a growing list of state and local governments...
    Purdue Pharma agrees to pay $270 million to settle opioid case

    Purdue Pharma agrees to pay $270 million to settle opioid case

    Medical Dialogues Bureau28 March 2019 9:15 AM IST
    Purdue Pharma introduced OxyContin in the 1990s and marketed it hard to doctors, making tens of billions of dollars from the drug. But the company has...
    Supreme Court lifts ban on Saridon, major relief to Piramal

    Supreme Court lifts ban on Saridon, major relief to Piramal

    Meghna A Singhania21 Feb 2019 6:05 PM IST
    New Delhi: In a major relief to Piramal, the Supreme Court has exempted the popular painkiller drug Saridon from the list of Fixed Dose Combinations...
    Next

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok